Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
The Ted Rogers Centre and its partners are committed to helping commercialize new cardiovascular innovations and technologies so they may reach the market sooner.
The ECHO program is a key part of that mission – and is open to any Canadian-based clinician, scientist, entrepreneur and/or student. Applications for the 2020-21 year closed on August 28th.
To reach teams across Canada, ECHO is now entirely virtual, beginning in 2020. We are pleased to announce a call for applications for the 2020-2021 ECHO program.
Founded in 2018, ECHO is a 12-month online training program led by veteran entrepreneurs and high-calibre consultants across a variety of sectors. Comprised of a unique combination of five complementary modules, ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, and networking opportunities, and the chance to pitch for start-up funding from a $250,000 pool.
Please visit our ECHO website for more details.
ECHO is organized and funded by the Translational Biology and Engineering Program (TBEP) – the University of Toronto component of the Ted Rogers Centre for Heart Research – in partnership with the Health Innovation Hub (H2i), a University of Toronto campus-linked accelerator.
